Sunday Oct 25 | MarketWatch
Allergan wins ruling in patent dispute
Allergan Inc. won a ruling in federal court that its patents on Alphagan, which lowers pressure in the eye in patients with open-angle glaucoma and ocular hypertension, were infringed.
Allergan Announces Victory in Brimonidine Patent Infringement Case
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc.
VEGF Studies May Bring New AMD Treatment
Activated forms of vascular endo-thelial growth factor and platelet-derived growth factor receptors, previously not known to exist in the vitreous, have been found to correlate with response to anti-VEGF therapy in wet age-related macular degeneration, according to researchers in Maryland and Virginia .
Something old, something new: Novel preparation of unlikely drugs offers rosacea relief
National report - What do Afrin and brimonidine have in common with rosacea? Believe it or not, both medications - a nasal decongestant and glaucoma eye drops - are the basis for some exciting new treatment possibilities for the chronic skin disorder.
Clinical Sciences: Experimental and Clinical Evidence for Brimonidine ...
Objective To review the available evidence for the neuroprotective qualities of brimonidine tartrate in optic nerve and retinal injury.
Also on Topix